A Study to Learn About the Study Medicine (Called Avelumab) in People With Advanced Urothelial Cancer After Chemotherapy
Clinical trial NCT05366725 · COMPLETED
Trial details
- NCT number
- NCT05366725
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-06-29
- Primary completion
- 2024-06-27
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.